Functional evaluation of novel variants of B4GALNT1 in a patient with hereditary spastic paraplegia and the general population

被引:1
|
作者
Inamori, Kei-ichiro [1 ]
Nakamura, Katsuya [2 ,3 ]
Shishido, Fumi [4 ]
Hsu, Jia-Chen [1 ]
Nagafuku, Masakazu [1 ]
Nitta, Takahiro [1 ,5 ,6 ]
Ikeda, Junji [2 ]
Yoshimura, Hidekane [7 ]
Kodaira, Minori [2 ]
Tsuchida, Naomi [8 ,9 ]
Matsumoto, Naomichi [8 ]
Uemura, Satoshi [10 ]
Ohno, Shiho [11 ]
Manabe, Noriyoshi [11 ]
Yamaguchi, Yoshiki [11 ]
Togayachi, Akira [12 ]
Aoki-Kinoshita, Kiyoko F. [12 ]
Nishihara, Shoko [12 ]
Furukawa, Jun-ichi [13 ]
Kaname, Tadashi [14 ]
Nakamura, Masahiko [15 ]
Shimohata, Takayoshi [16 ]
Tadaka, Shu [17 ]
Shirota, Matsuyuki [17 ]
Kinoshita, Kengo [17 ]
Nakamura, Yutaka [4 ]
Ohno, Isao [4 ]
Sekijima, Yoshiki [2 ]
Inokuchi, Jin-ichi [18 ]
机构
[1] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Sendai, Japan
[2] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Japan
[3] Shinshu Univ Hosp, Ctr Med Genet, Matsumoto, Japan
[4] Tohoku Med & Pharmaceut Univ, Fac Med, Ctr Med Educ, Sendai, Japan
[5] Juntendo Univ, Fac Pharm, Lab Bioregulatory Clin Phamacol, Urayasu, Japan
[6] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan
[7] Shinshu Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Matsumoto, Japan
[8] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Japan
[9] Yokohama City Univ Med, Dept Rare Dis Genom, Yokohama, Japan
[10] Tohoku Med & Pharmaceut Univ, Fac Med, Div Med Biochem, Sendai, Japan
[11] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Struct Glycobiol, Sendai, Japan
[12] Soka Univ, Glycan & Life Syst Integrat Ctr GaLSIC, Hachioji, Japan
[13] Nagoya Univ, Inst Glycocore Res iGCORE, Nagoya, Japan
[14] Natl Ctr Child Hlth & Dev, Dept Genome Med, Tokyo, Japan
[15] Matsumoto City Hosp, Dept Neurosurg, Matsumoto, Japan
[16] Gifu Univ, Grad Sch Med, Dept Neurol, Gifu, Japan
[17] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Japan
[18] Osaka Univ, Forefront Res Ctr, Grad Sch Sci, Toyonaka, Japan
关键词
hereditary spastic paraplegia; gangliosides; B4GALNT1; GM2/GD2; synthase; glycosyltransferase; missense variant; MYELIN-ASSOCIATED GLYCOPROTEIN; EXPRESSION CLONING; COMPLEX GANGLIOSIDES; SYNTHASE; MICE; CDNA; SPECIFICITY; DEFICIENT; LIGANDS; BIOLOGY;
D O I
10.3389/fnins.2024.1437668
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Hereditary spastic paraplegia (HSP) is a heterogeneous group of neurological disorders that are characterized by progressive spasticity and weakness in the lower limbs. SPG26 is a complicated form of HSP, which includes not only weakness in the lower limbs, but also cognitive impairment, developmental delay, cerebellar ataxia, dysarthria, and peripheral neuropathy, and is caused by biallelic mutations in the B4GALNT1 (beta-1,4-N-acetylgalactosaminyltransferase 1) gene. The B4GALNT1 gene encodes ganglioside GM2/GD2 synthase (GM2S), which catalyzes the transfer of N-acetylgalactosamine to lactosylceramide, GM3, and GD3 to generate GA2, GM2, and GD2, respectively. The present study attempted to characterize a novel B4GALNT1 variant (NM_001478.5:c.937G>A p.Asp313Asn) detected in a patient with progressive multi-system neurodegeneration as well as deleterious variants found in the general population in Japan. Peripheral blood T cells from our patient lacked the ability for activation-induced ganglioside expression assessed by cell surface cholera toxin binding. Structural predictions suggested that the amino acid substitution, p.Asp313Asn, impaired binding to the donor substrate UDP-GalNAc. An in vitro enzyme assay demonstrated that the variant protein did not exhibit GM2S activity, leading to the diagnosis of HSP26. This is the first case diagnosed with SPG26 in Japan. We then extracted 10 novel missense variants of B4GALNT1 from the whole-genome reference panel jMorp (8.3KJPN) of the Tohoku medical megabank organization, which were predicted to be deleterious by Polyphen-2 and SIFT programs. We performed a functional evaluation of these variants and demonstrated that many showed perturbed subcellular localization. Five of these variants exhibited no or significantly decreased GM2S activity with less than 10% activity of the wild-type protein, indicating that they are carrier variants for HSP26. These results provide the basis for molecular analyses of B4GALNT1 variants present in the Japanese population and will help improve the molecular diagnosis of patients suspected of having HSP.
引用
收藏
页数:12
相关论文
共 38 条
  • [31] AP4B1-associated hereditary spastic paraplegia: expansion of phenotypic spectrum related to homozygous p.Thr387fs variant
    Szczaluba, Krzysztof
    Mierzewska, Hanna
    Smigiel, Robert
    Kosinska, Joanna
    Koppolu, Agnieszka
    Biernacka, Anna
    Stawinski, Piotr
    Pollak, Agnieszka
    Rydzanicz, Malgorzata
    Ploski, Rafal
    JOURNAL OF APPLIED GENETICS, 2020, 61 (02) : 213 - 218
  • [32] Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report
    Ruan, Wen-Cong
    Wang, Jia
    Yu, Yong-Lin
    Che, Yue-Ping
    Ding, Li
    Li, Chen-Xi
    Wang, Xiao-Dong
    Li, Hai-Feng
    BMC MEDICAL GENETICS, 2020, 21 (01)
  • [33] Novel compound heterozygous variants in KIF1A non-motor domain of recessive hereditary spastic paraplegia type 30: a case with 65-year disease history
    Zheng, Xiaosheng
    Luo, Wei
    NEUROLOGICAL SCIENCES, 2024, : 1933 - 1935
  • [34] A Novel Homozygous p. R1105X Mutation of the AP4E1 Gene in Twins with Hereditary Spastic Paraplegia and Mycobacterial Disease
    Kong, Xiao-Fei
    Bousfiha, Aziz
    Rouissi, Abdelfettah
    Itan, Yuval
    Abhyankar, Avinash
    Bryant, Vanessa
    Okada, Satoshi
    Ailal, Fatima
    Bustamante, Jacinta
    Casanova, Jean-Laurent
    Hirst, Jennifer
    Boisson-Dupuis, Stephanie
    PLOS ONE, 2013, 8 (03):
  • [35] Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalization
    Scarrott, Joseph M.
    Alves-Cruzeiro, Joao
    Marchi, Paolo M.
    Webster, Christopher P.
    Yang, Zih-Liang
    Karyka, Evangelia
    Marroccella, Raffaele
    Coldicott, Ian
    Thomas, Hannah
    Azzouz, Mimoun
    BRAIN COMMUNICATIONS, 2022, 5 (01)
  • [36] Functional Characterization of Two Novel Intron 4 SERPING1 Gene Splice Site Pathogenic Variants in Families with Hereditary Angioedema
    Shchagina, Olga
    Gracheva, Elena
    Chukhrova, Alyona
    Bliznets, Elena
    Bychkov, Igor
    Kutsev, Sergey
    Polyakov, Aleksander
    BIOMEDICINES, 2024, 12 (01)
  • [37] Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5)
    Hoeflinger, Philip
    Theurer, Yvonne
    Schuele, Rebecca
    Schoels, Ludger
    Hauser, Stefan
    STEM CELL RESEARCH, 2016, 17 (02) : 422 - 425
  • [38] Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47)
    Teinert, Julian
    Behne, Robert
    D'Amore, Angelica
    Wimmer, Miriam
    Dwyer, Sean
    Chen, Teresa
    Buttermore, Elizabeth D.
    Chen, Ivy Pin-Fang
    Sahin, Mustafa
    Ebrahimi-Fakhari, Darius
    STEM CELL RESEARCH, 2019, 40